This Year's Sponsors

Asimov’s mission is to advance humanity’s ability to design living systems, enabling biotechnologies with outsized societal benefit. The company is developing a synthetic biology platform – from cells to software – to design and manufacture next-generation therapeutics, including cell & gene therapies, through a combination of products, services, & collaborations. Founded by bioengineers from MIT and Boston University and headquartered in Boston, the company has raised over $200 million to date.

Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 30 years of experience producing monoclonal antibodies and recombinant proteins, Avid’s services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization.

INCOG BioPharma Services is designed and built based on decades of experience with a clear purpose: to be a customer-driven CDMO providing a new standard of excellence for injectable drug products.

The company’s service offering includes filling drug products into vials, syringes, and cartridges. INCOG BioPharma also offers support services, including analytical development, stability testing and storage, final inspection, labeling, packaging, and device assembly.

We go above and beyond to understand your requirements, meet your needs, and foster a collaborative partnership. Experience better and discover the INCOG way.

L7 Informatics reimagines data intelligence for modern life sciences and healthcare organizations. Beyond simple data management, L7 provides tools that optimize the flow of information between process and people, unlocking innovation at every stage of the clinical, research, and manufacturing value chains. Our comprehensive operating environment and software stack bring flexible, secure, and collaborative data intelligence to your entire operation. From regulatory compliance and workflow orchestration to customized applications and integrations, our end-to-end transformation engine helps organizations solve today’s challenges and realize tomorrow’s opportunities. L7|ESP™ is designed to unlock innovation at every stage of the clinical, research, and manufacturing value chain. From data and workflow orchestration to custom apps and integrations, L7|ESP is an end-to-end transformation engine to help solve today’s challenges and realize tomorrow’s opportunities.

The L7 Manufacturing Execution System (MES) offers a unified platform approach to manufacturing operations management. While traditional MES is rigid and siloed from other systems and equipment, leaving operations still relying on forms and spreadsheets, L7 MES provides a holistic manufacturing operations management experience. Additionally, the L7 MES system is designed for developing and progressing seamlessly to CGMP production. We are CGMP-ready and provide the flexibility to support the early-stage process development, capturing and curating your data resource across your journey to clinical and commercial production.

For the past 20+ years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. As the world’s largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners’ most high-profile drug and device programs.

Resilience is a technology-focused manufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company aims to build a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely and at scale. By continuously advancing the science of biopharmaceutical manufacturing and development, Resilience seeks to free its partners to focus on the discoveries that improve patients’ lives.